Moreover, the SYVN1 enzyme activity inhibitor LS-102, which has potential applications in the study of rheumatoid arthritis and obesity [37–39], inhibits cell proliferation induced by SYVN1. This evidence concerns the gene SYVN1 and obesity due to melanocortin 4 receptor deficiency.